Talk:Duocarmycin

Hello fellow Wikipedians,

I have just modified one external link on Duocarmycin. Please take a moment to review [https://en.wikipedia.org/w/index.php?diff=prev&oldid=800660207 my edit]. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

• Added archive https://archive.is/20141126193402/http://adcreview.com/uncategorized/duocarmycin-analogues-2/ to http://adcreview.com/uncategorized/duocarmycin-analogues-2/

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

{{sourcecheck|checked=false|needhelp=}}

Cheers.—InternetArchiveBot (Report bug) 22:32, 14 September 2017 (UTC)

Per Wikipedia:Copyright_problems/2020_February_28, there were some sections here that seemed to be copy/pasted from various sources.

• The "Carzelesin" subsection added here in 2013 is copy/pasted from [https://cancerres.aacrjournals.org/content/52/18/4904.long this 1992 paper].
• About half the "Ducarmycin analogues vs. tubulin binders" subsection, added in Oct 2013 was copy/pasted from [https://www.fiercebiotech.com/research/synthon-biopharmaceuticals-reports-positive-early-results-its-second-generation-her2 this Jan 2013 press release].
• Most of the "Bizelesin" subsection, also added in 2013 is copy/pasted from [https://mct.aacrjournals.org/content/2/7/651.long a 2003 paper].
• "Adozelesin" subsection was added at the same time, copy/pasted from [https://mct.aacrjournals.org/content/2/1/41.long another 2003 paper].

I've deleted the page revisions going back to the first copyvio-free diff I could find. Apologies for the disruption. If anyone has questions, please let me know. Ajpolino (talk) 06:09, 9 October 2020 (UTC)